D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show whether D-cycloserine in combination with cognitive
behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of
posttraumatic stress disorder (PTSD) in 13-18 year-old children.
Phase:
Phase 2
Details
Lead Sponsor:
Tulane University School of Medicine
Collaborator:
National Alliance for Research on Schizophrenia and Depression